Pedro Mezquita Raya

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

Obesity, Metabolic Syndrome, Nutrition +8

Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin

Antonio Pérez, Pedro Mezquita Raya, Antonio Ramírez de Arellano et al. · Diabetes Therapy · 2015 · 29 citations · Full text

The Economic Burden of Insulin-Related Hypoglycemia in Spain

Witesh Parekh, Nicki Hoskins, James Baker‐Knight et al. · Diabetes Therapy · 2017 · 28 citations · Full text

Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin

Pedro Mezquita Raya, Antonio Pérez, Antonio Ramírez de Arellano et al. · Diabetes Therapy · 2013 · 25 citations · Full text